InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Sorrento Therapeutics, Inc.. Director active across 2 companies, notably Scilex Holding Co. Cumulatively, 3 disclosures have been published. Breakdown: 0 buy · 2 sells. History available since 19 January 2023. The latest transaction was disclosed on 19 January 2023 (J). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations